Activation of hepatocyte growth factor receptor, c-met, in renal tubules is required for renoprotection after acute kidney injury

Kidney International

Volumn 84, Issue 3, 2013, Pages 509-520

  Zhou, Dong ^a   Tan, Roderick J ^a   Lin, Lin ^a   Zhou, Lili ^a,b   Liu, Youhua ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

acute kidney injury; apoptosis; c met; HGF; inflammation

Indexed keywords

CHEMOKINE; CISPLATIN; CREATININE; FAS LIGAND; PROTEIN BAX; PROTEIN KINASE B; SCATTER FACTOR; SCATTER FACTOR RECEPTOR;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE DISRUPTION; IN VIVO STUDY; KIDNEY FUNCTION; KIDNEY TUBULE; KIDNEY TUBULE EPITHELIUM; KNOCKOUT MOUSE; MOUSE; MOUSE STRAIN; NEPHRITIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RENAL PROTECTION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TISSUE REGENERATION; TISSUE REPAIR;

ACUTE KIDNEY INJURY; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CISPLATIN; CREATININE; DISEASE MODELS, ANIMAL; FAS LIGAND PROTEIN; KIDNEY TUBULES; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; PROTO-ONCOGENE PROTEINS C-MET; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

EID: 84883455006     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2013.102     Document Type: Article

References (42)

1. Pabla N, Dong Z. Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies. Kidney Int 2008; 73: 994-1007.
2. Bonventre JV, Weinberg JM. Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 2003; 14: 2199-2210.
3. Ramesh G, Reeves WB. TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest 2002; 110: 835-842.
4. Havasi A, Borkan SC. Apoptosis and acute kidney injury. Kidney Int 2011; 80: 29-40.
5. Sharfuddin AA, Molitoris BA. Pathophysiology of ischemic acute kidney injury. Nat Rev Nephrol 2011; 7: 189-200.
6. Linkermann A, Brasen JH, Himmerkus N et al. Rip1 (receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury. Kidney Int 2012; 81: 751-761.
7. Liu Y. Hepatocyte growth factor in kidney fibrosis: Therapeutic potential and mechanisms of action. Am J Physiol Renal Physiol 2004; 287: F7-F16.
8. Nakamura T, Sakai K, Matsumoto K. Hepatocyte growth factor twenty years on: Much more than a growth factor. J Gastroenterol Hepatol 2011; 26(Suppl 1): 188-202.
9. Liu ZX, Nickel CH, Cantley LG. HGF promotes adhesion of ATP-depleted renal tubular epithelial cells in a MAPK-dependent manner. Am J Physiol Renal Physiol 2001; 281: F62-F70.
10. Trusolino L, Bertotti A, Comoglio PM. MET signalling: Principles and functions in development, organ regeneration and cancer. Nat Rev Mol Cell Biol 2010; 11: 834-848.
11. Zhang X, Li Y, Dai C et al. Sp1 and Sp3 transcription factors synergistically regulate HGF receptor gene expression in kidney. Am J Physiol Renal Physiol 2003; 284: F82-F94.
12. Herrero-Fresneda I, Torras J, Franquesa M et al. HGF gene therapy attenuates renal allograft scarring by preventing the profibrotic inflammatory-induced mechanisms. Kidney Int 2006; 70: 265-274.
13. Gong R, Rifai A, Dworkin LD. Hepatocyte growth factor suppresses acute renal inflammation by inhibition of endothelial E-selectin. Kidney Int 2006; 69: 1166-1174.
14. Giannopoulou M, Dai C, Tan X et al. Hepatocyte growth factor exerts its anti-inflammatory action by disrupting nuclear factor-kB signaling. Am J Pathol 2008; 173: 30-41.
15. Zhang J, Yang J, Liu Y. Role of Bcl-xL induction in HGF-mediated renal epithelial cell survival after oxidant stress. Int J Clin Exp Pathol 2008; 1: 242-253.
16. Liu Y. Hepatocyte growth factor and the kidney. Curr Opin Nephrol Hypertens 2002; 11: 23-30.
17. Rabkin R, Fervenza F, Tsao T et al. Hepatocyte growth factor receptor in acute tubular necrosis. J Am Soc Nephrol 2001; 12: 531-540.
18. Liu Y, Tolbert EM, Lin L et al. Up-regulation of hepatocyte growth factor receptor: An amplification and targeting mechanism for hepatocyte growth factor action in acute renal failure. Kidney Int 1999; 55: 442-453.
19. Dai C, Saleem MA, Holzman LB et al. Hepatocyte growth factor signaling ameliorates podocyte injury and proteinuria. Kidney Int 2010; 77: 962-973.
20. Ma H, Saenko M, Opuko A et al. Deletion of the Met receptor in the collecting duct decreases renal repair after ureteral obstruction. Kidney Int 2009; 76: 868-876.
21. Sheikh-Hamad D, Timmins K, Jalali Z. Cisplatin-induced renal toxicity: Possible reversal by N-acetylcysteine treatment. J Am Soc Nephrol 1997; 8: 1640-1644.
22. Dai C, Huh CG, Thorgeirsson SS et al. b-Cell-specific ablation of the hepatocyte growth factor receptor results in reduced islet size, impaired insulin secretion, and glucose intolerance. Am J Pathol 2005; 167: 429-436.
23. Gardai SJ, Hildeman DA, Frankel SK et al. Phosphorylation of Bax Ser184 by Akt regulates its activity and apoptosis in neutrophils. J Biol Chem 2004; 279: 21085-21095.
24. Ruiz-Vela A, Opferman JT, Cheng EH et al. Proapoptotic BAX and BAK control multiple initiator caspases. EMBO Rep 2005; 6: 379-385.
25. Wei MC, Zong WX, Cheng EH et al. Proapoptotic BAX and BAK: A requisite gateway to mitochondrial dysfunction and death. Science 2001; 292: 727-730.
26. Zhou D, Li Y, Lin L et al. Tubule-specific ablation of endogenous b-catenin aggravates acute kidney injury. Kidney Int 2012; 82: 537-547.
27. Dai C, Yang J, Liu Y. Single injection of naked plasmid encoding hepatocyte growth factor prevents cell death and ameliorates acute renal failure in mice. J Am Soc Nephrol 2002; 13: 411-422.
28. Yang J, Chen S, Huang L et al. Sustained expression of naked plasmid DNA encoding hepatocyte growth factor in mice promotes liver and overall body growth. Hepatology 2001; 33: 848-859.
29. Mizuno S, Matsumoto K, Nakamura T. HGF as a renotrophic and antifibrotic regulator in chronic renal disease. Front Biosci 2008; 13: 7072-7086.
30. Huh CG, Factor VM, Sanchez A et al. Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair. Proc Natl Acad Sci USA 2004; 101: 4477-4482.
31. Ciarimboli G, Deuster D, Knief A et al. Organic cation transporter 2 mediates cisplatin-induced oto- and nephrotoxicity and is a target for protective interventions. Am J Pathol 2010; 176: 1169-1180.
32. Shao X, Somlo S, Igarashi P. Epithelial-specific Cre/lox recombination in the developing kidney and genitourinary tract. J Am Soc Nephrol 2002; 13: 1837-1846.
33. Kinsey GR, Li L, Okusa MD. Inflammation in acute kidney injury. Nephron Exp Nephrol 2008; 109: E102-e107.
34. Vasudevan KM, Garraway LA. AKT signaling in physiology and disease. Curr Top Microbiol Immunol 2010; 347: 105-133.
35. Liu Y. Hepatocyte growth factor promotes renal epithelial cell survival by dual mechanisms. Am J Physiol Renal Physiol 1999; 277: F624-F633.
36. Villa-Morales M, Fernandez-Piqueras J. Targeting the Fas/FasL signaling pathway in cancer therapy. Expert Opin Ther Targets 2012; 16: 85-101.
37. Lettau M, Paulsen M, Schmidt H et al. Insights into the molecular regulation of FasL (CD178) biology. Eur J Cell Biol 2011; 90: 456-466.
38. Coudriet GM, He J, Trucco M et al. Hepatocyte growth factor modulates interleukin-6 production in bone marrow derived macrophages: Implications for inflammatory mediated diseases. PLoS ONE 2011; 5: E15384.
39. Wei Q, Dong G, Franklin J et al. The pathological role of Bax in cisplatin nephrotoxicity. Kidney Int 2007; 72: 53-62.
40. Dai C, Yang J, Bastacky S et al. Intravenous administration of hepatocyte growth factor gene ameliorates diabetic nephropathy in mice. J Am Soc Nephrol 2004; 15: 2637-2647.
41. Tan X, He W, Liu Y. Combination therapy with paricalcitol and trandolapril reduces renal fibrosis in obstructive nephropathy. Kidney Int 2009; 76: 1248-1257.
42. Ding H, Zhou D, Hao S et al. Sonic hedgehog signaling mediates epithelial-mesenchymal communication and promotes renal fibrosis. J Am Soc Nephrol 2012; 23: 801-813.